| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11010-014-2002-X |
| P698 | PubMed publication ID | 24604673 |
| P2093 | author name string | Walid Hamdy El-Tantawy | |
| Ekram Nemr Abd Al Haleem | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes | Q24644691 | ||
| Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 | ||
| Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views | Q28251015 | ||
| Glutathione S-transferases. The first enzymatic step in mercapturic acid formation | Q29547415 | ||
| Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves | Q33654318 | ||
| Mesenchymal stem cell therapy: Two steps forward, one step back | Q33898653 | ||
| Oxidative stress and cancer: have we moved forward? | Q34001313 | ||
| Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals | Q34327569 | ||
| Improved glycemic control, pancreas protective and hepatoprotective effect by traditional poly-herbal formulation "Qurs Tabasheer" in streptozotocin induced diabetic rats. | Q34543605 | ||
| Reactive oxygen species in the vasculature: molecular and cellular mechanisms | Q35569201 | ||
| Mesenchymal stem cells: isolation and therapeutics | Q35877577 | ||
| Mesenchymal stem cells for the treatment of diabetes | Q35976665 | ||
| Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity | Q35976735 | ||
| Focus on oxidative stress in the cardiovascular and renal systems | Q35983896 | ||
| The potential for stem cell therapy in diabetes. | Q36426351 | ||
| Modification of mesenchymal stem cells for cardiac regeneration. | Q37687406 | ||
| Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials | Q37777103 | ||
| MSCs: Biological characteristics, clinical applications and their outstanding concerns | Q37781509 | ||
| Two methods for the determination of glycogen in liver | Q39244134 | ||
| Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | Q40321403 | ||
| Dyslipidemia and diabetes: animal models. | Q40452136 | ||
| Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice | Q45868872 | ||
| Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats. | Q46275300 | ||
| The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. | Q47695204 | ||
| Adipose-derived mesenchymal stem cells ameliorate STZ-induced pancreas damage in type 1 diabetes. | Q51327408 | ||
| Levels of serum sialic acid and thiobarbituric acid reactive substances in subjects with impaired glucose tolerance and type 2 diabetes mellitus. | Q51463680 | ||
| Streptozotocin- and alloxan-induced diabetes modifies total plasma and lipoprotein lipid concentration and composition without altering cholesteryl ester transfer activity. | Q51490915 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. | Q51751379 | ||
| Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats. | Q51804359 | ||
| Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase | Q68355661 | ||
| A simplified quick method for determination of sialic acid in serum | Q70125939 | ||
| [Bioenergetics of liver mitochondria in rats in experimental insulin-dependent diabetes] | Q73036767 | ||
| Intraportal injection of insulin-producing cells generated from human bone marrow mesenchymal stem cells decreases blood glucose level in diabetic rats | Q86959867 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | hyperglycemia | Q271993 |
| P304 | page(s) | 193-200 | |
| P577 | publication date | 2014-03-07 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | Therapeutic effects of stem cell on hyperglycemia, hyperlipidemia, and oxidative stress in alloxan-treated rats | |
| P478 | volume | 391 |
| Q28078407 | Current progress of human trials using stem cell therapy as a treatment for diabetes mellitus |
| Q38290087 | Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives. |
| Q89147848 | Differentiation of umbilical cord mesenchymal stem cells into hepatocytes in comparison with bone marrow mesenchymal stem cells |
| Q38606215 | Effect of Microenvironment on Differentiation of Human Umbilical Cord Mesenchymal Stem Cells into Hepatocytes In Vitro and In Vivo |
| Q37460214 | Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes |
| Q92366771 | Overexpression of long noncoding RNA CUDR promotes hepatic differentiation of human umbilical cord mesenchymal stem cells |
| Q92308857 | Systematically transplanted human gingiva-derived mesenchymal stem cells regulate lipid metabolism and inflammation in hyperlipidemic mice with periodontitis |
Search more.